April 16 (Reuters) - Novavax Inc NVAX.O :
* NOVAVAX TO COMMENCE COVID-19 VACCINE TRIAL WITH NUCLEUS NETWORK
* PHASE 1 TRIAL OF NVX-COV2373 IS EXPECTED TO BEGIN IN MID-MAY WITH PRELIMINARY IMMUNOGENICITY AND SAFETY RESULTS IN JULY
* NOVAVAX-COMMENCE TRIAL WITH AUSTRALIAN BASED NUCLEUS NETWORK FOR NOVAVAX SARS-COV-2 RECOMBINANT SPIKE PROTEIN NANOPARTICLE VACCINE WITHIN COMING WEEKS